Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol
AUTOR(ES)
Després, Jean-Pierre
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=81626Documentos Relacionados
- Why are low-density lipoproteins atherogenic?
- Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations.
- High-density lipoprotein, low-density lipoprotein, and coronary heart disease.
- Low-density lipoprotein oxidation and the pathogenesis of atherosclerosis.
- RFLPs upstream of the low-density lipoprotein receptor (LDLR) gene.